Answers are grounded in this paper and cite their sources.
Improved glycemic control of type 2 DM is associated with substantial short-term symptomatic, QOL, and health economic benefits.
No takes yet. Share an insight, caveat, or question.
Testa et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: